Cubist Systematic Strategies, LLC Absci Corp Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.41 - $5.74 $7,935 - $13,356	-2,327 Reduced 3.55%	63,160 $358,000
Q4 2023 Feb 14, 2024	BUY	$1.15 - $4.79 $14,464 - $60,248	12,578 Added 23.77%	65,487 $275,000
Q3 2023 Nov 14, 2023	SELL	$1.28 - $2.41 $72,901 - $137,259	-56,954 Reduced 51.84%	52,909 $69,000
Q2 2023 Aug 14, 2023	BUY	$1.17 - $2.03 $128,539 - $223,021	109,863 New	109,863 $166,000
Q4 2022 Feb 14, 2023	BUY	$2.0 - $3.58 $49,200 - $88,068	24,600 Added 153.63%	40,613 $85,000
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.83 $47,238 - $77,342	16,013 New	16,013 $50,000
Q4 2021 Feb 14, 2022	SELL	$7.88 - $18.03 $391,903 - $896,704	-49,734 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.37 - $30.29 $515,741 - $1.51 Million	49,734 New	49,734 $578,000

127

59.1M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $249M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.